194 related articles for article (PubMed ID: 25161061)
1. Modulation of mast cell proliferative and inflammatory responses by leukotriene d4 and stem cell factor signaling interactions.
Al-Azzam N; Kondeti V; Duah E; Gombedza F; Thodeti CK; Paruchuri S
J Cell Physiol; 2015 Mar; 230(3):595-602. PubMed ID: 25161061
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of cysteinyl leukotriene receptor signaling by protein kinase C in human mast cells.
Kondeti V; Duah E; Al-Azzam N; Thodeti CK; Boyce JA; Paruchuri S
PLoS One; 2013; 8(8):e71536. PubMed ID: 23977066
[TBL] [Abstract][Full Text] [Related]
3. CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells.
Jiang Y; Borrelli LA; Kanaoka Y; Bacskai BJ; Boyce JA
Blood; 2007 Nov; 110(9):3263-70. PubMed ID: 17693579
[TBL] [Abstract][Full Text] [Related]
4. Protein Kinase C α and β compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation.
Teegala LR; Elshoweikh Y; Gudneppanavar R; Thodeti S; Pokhrel S; Southard E; Thodeti CK; Paruchuri S
FASEB J; 2022 May; 36(5):e22273. PubMed ID: 35349200
[TBL] [Abstract][Full Text] [Related]
5. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
[TBL] [Abstract][Full Text] [Related]
6. Stem cell factor expression, mast cells and inflammation in asthma.
Da Silva CA; Reber L; Frossard N
Fundam Clin Pharmacol; 2006 Feb; 20(1):21-39. PubMed ID: 16448392
[TBL] [Abstract][Full Text] [Related]
7. Activation of KIT modulates the function of tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) in mast cells.
Förster A; Grotha SP; Seeger JM; Rabenhorst A; Gehring M; Raap U; Létard S; Dubreuil P; Kashkar H; Walczak H; Roers A; Hartmann K
Allergy; 2015 Jul; 70(7):764-74. PubMed ID: 25833810
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: Interleukin 4-dependent mast cell proliferation requires autocrine/intracrine cysteinyl leukotriene-induced signaling.
Jiang Y; Kanaoka Y; Feng C; Nocka K; Rao S; Boyce JA
J Immunol; 2006 Sep; 177(5):2755-9. PubMed ID: 16920908
[TBL] [Abstract][Full Text] [Related]
9. RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.
Kalesnikoff J; Rios EJ; Chen CC; Nakae S; Zabel BA; Butcher EC; Tsai M; Tam SY; Galli SJ
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2659-64. PubMed ID: 16533754
[TBL] [Abstract][Full Text] [Related]
10. RIN3 is a negative regulator of mast cell responses to SCF.
Janson C; Kasahara N; Prendergast GC; Colicelli J
PLoS One; 2012; 7(11):e49615. PubMed ID: 23185384
[TBL] [Abstract][Full Text] [Related]
11. SCF-induced airway hyperreactivity is dependent on leukotriene production.
Oliveira SH; Hogaboam CM; Berlin A; Lukacs NW
Am J Physiol Lung Cell Mol Physiol; 2001 Jun; 280(6):L1242-9. PubMed ID: 11350804
[TBL] [Abstract][Full Text] [Related]
12. Lipid mediator Leukotriene D
Dholia N; Yadav UCS
Prostaglandins Other Lipid Mediat; 2018 May; 136():55-63. PubMed ID: 29751150
[TBL] [Abstract][Full Text] [Related]
13. CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation.
Ravasi S; Citro S; Viviani B; Capra V; Rovati GE
Respir Res; 2006 Mar; 7(1):42. PubMed ID: 16553950
[TBL] [Abstract][Full Text] [Related]
14. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.
Bautz F; Denzlinger C; Kanz L; Möhle R
Blood; 2001 Jun; 97(11):3433-40. PubMed ID: 11369634
[TBL] [Abstract][Full Text] [Related]
15. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
[TBL] [Abstract][Full Text] [Related]
16. Leukotriene D4 accelerates antigen-mediated mast cell responses via the cysteinyl leukotriene 1 receptor.
Fujisawa S; Nagata Y; Suzuki R
Cell Immunol; 2022 Dec; 382():104632. PubMed ID: 36274438
[TBL] [Abstract][Full Text] [Related]
17. A novel KIT-deficient mouse mast cell model for the examination of human KIT-mediated activation responses.
Smrž D; Bandara G; Zhang S; Mock BA; Beaven MA; Metcalfe DD; Gilfillan AM
J Immunol Methods; 2013 Apr; 390(1-2):52-62. PubMed ID: 23357051
[TBL] [Abstract][Full Text] [Related]
18. P2Y6 receptors require an intact cysteinyl leukotriene synthetic and signaling system to induce survival and activation of mast cells.
Jiang Y; Borrelli L; Bacskai BJ; Kanaoka Y; Boyce JA
J Immunol; 2009 Jan; 182(2):1129-37. PubMed ID: 19124756
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity in the responses of human lung mast cells to stem cell factor.
Lewis A; Wan J; Baothman B; Monk PN; Suvarna SK; Peachell PT
Clin Exp Allergy; 2013 Jan; 43(1):50-9. PubMed ID: 23278880
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib stimulates human skin type mast cell degranulation and maturation.
Mizukami Y; Sugawara K; Kira Y; Tsuruta D
J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
